IGI Logo

Mumbai : The Board of Directors of JM Financial Limited, at its meeting held today, approved the unaudited financial results for the second quarter and half year ended September 30, 2021.

Summary of Consolidated results FY 22 – Q2 compared to FY 21 – Q2

Summary of Consolidated results FY 22 – H1 compared to FY 21 – H1

The earnings per share for the half year ended September 30, 2021 is Rs. 3.96. The consolidated net worth* as at September 30, 2021 stands at Rs. 7,281 Cr and the gross debt equity (equity of Rs. 7,281 Cr + non-controlling interest of Rs. 2,725 Cr) ratio is 1.08 times* and net debt equity of 0.68 times* (post reducing cash and cash equivalents of Rs. 3,957 Cr). The book value per share is Rs. 76.35.

Our consolidated loan book** stood at Rs. 11,072 Cr as of September 30, 2021 compared to Rs. 11,386 Cr as of September 30, 2020. Gross NPA and Net NPA stood at 2.32% and 1.38% respectively as of September 30, 2021 compared to 1.69% and 1.13% respectively as of September 30, 2020. The loan book under the Resolution Framework for Covid-19 announced by RBI stood at 0.87% as of September 30, 2021 (0.62% as of June 30, 2021).

We have made additional gross provisions of Rs. 76 Cr# on account of the uncertainties around Covid-19 for the quarter ended September 30, 2021, thereby taking the total provisions (net of reversals) to Rs. 559 Cr# on account of the pandemic.

Commenting on the results and financial performance, Mr. Vishal Kampani, Non-executive Vice Chairman, JM Financial Limited, said,

“The economy is showing signs of revival with growth impulses picking up pace, thus paving the way for the economy to gain escape velocity from the pandemic.

We have delivered another strong quarter and the numbers look encouraging reflecting sustainable growth. We achieved a significant milestone, wherein the total consolidated networth including the non-controlling interests has crossed Rs.10,000 Cr. We continue to diversify our liabilities franchise and have successfully concluded the public issue of secured Non-Convertible Debentures by JM Financial Products Limited of Rs. 500 Cr.

As economic activities are gradually coming back to normal, we are well positioned to drive value for our stakeholders banking on our robust balance sheet and diverse set of businesses.”

Business Update

Investment Bank​​​​​​​

During the quarter, our completed investment banking transactions include:

* Book Running Lead Manager to the

- Initial Public Offer of Equity Shares of Clean Science & Technology Limited (~Rs. 1,546 Cr), Krsnaa Diagnostics Limited (~Rs. 1,213 Cr), India Pesticides Limited (~Rs. 800 Cr), Rolex Rings Limited (~Rs. 713 Cr) and Tatva Chintan Pharma Chem Limited (~Rs. 500 Cr)

- Qualified Institutions Placement of Equity Shares of Bank of India Limited (~Rs. 2,550 Cr) and Canara Bank Limited (~Rs. 2,500 Cr)

* Sole Advisor to the Private Placement in Gupshup Technology India Private Limited (~Rs. 1,800 Cr)

* Lead Manager for the Public Issue of NCDs by Piramal Capital & Housing Finance Limited (~Rs. 850 Cr)

* Sole Broker to the Block trade of Equity Shares of NSE Limited (~Rs. 485 Cr) and Stove Kraft Limited (~Rs. 75 Cr)

* Sole Manager to the Buyback of Equity Shares of Insecticides India Limited (~Rs. 60 Cr)

* Exclusive Manager to the Open Offer to the public shareholders of Mphasis Limited by BCP Topco IX Pte. Ltd

* Exclusive Financial Advisor to Calibre Chemicals and its promoters on controlling stake sale to Everstone Capital

* Acquisition of 100% stake of Exide Life Insurance Company Limited by HDFC Life Insurance Company Limited. JM Financial Limited provided Fairness Opinion to the Board of Directors of HDFC Life Insurance Company Limited

To Read Complete Report & Disclaimer Click Here

Above views are of the author and not of the website kindly read disclaimer